New Evidence and Emerging Strategies in the Management of Testicular Cancer In Vivo and In Vitro
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 4786
Special Issue Editors
Interests: molecular biology; cancer; cell line; cell culture; flow cytometry analysis; Western blotting; gene expression; sequencing; proteomics; seminoma cell line; prostate cancer cell lines
Special Issues, Collections and Topics in MDPI journals
Interests: cancer endocrinology; molecular biology; signal transduction; p75NTR-signaling; apoptosis; autophagy; EMT; renal and peritoneal fibrosis; inflammation; biological activity of natural compounds in cancer and chronic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Testicular germ cell tumors (TGCTs) are rare cancers that commonly occur in childhood, adolescence and the early stages of adulthood, whose incidence has been increasing in developed countries for at least four decades. In most cases, TGCTs are curable, but frequently these young patients are exposed to the long-term consequences of chemotherapy-related toxicity or the long-term side effects of radiotherapy, which can negatively impact fertility and sexual activity. Therefore, in recent decades, many researchers have focused their attention on targeting molecular pathways to develop new therapeutic approaches that mitigate these reported long-term effects. In this context, emerging in vitro and in vivo studies address some natural bioactive molecules, such as polyphenols and potential anti-cancer properties. Furthermore, recent studies focused on the epigenetic mechanisms associated with TGCT susceptibility, initiation, progression and response to chemotherapy, highlighting the importance of identifying epigenetic biomarkers as powerful tools for diagnostic, prognostic and epigenetic-based therapies.
Dr. Sabrina Bossio
Dr. Anna Perri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- testicular cancer
- fertility
- autocrine/paracrine regulators
- molecular mechanisms inflammation
- endocrine disruptors
- epigenetic biomarkers
